Positive results from early trial of drug that could protect brain cells
Date
News
Date
The grants will help activity providers deliver classes designed specifically for people with Parkinson’s.
Date
Over the next 3 years, the US-based Parkinson’s Foundation will invest a minimum of $3m (over £2.4m) into the Parkinson’s Virtual Biotech, our international drug discovery and development programme.
Date
2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson’s.
Date
A summary of the chancellor's cost of living support and what it means for people with Parkinson's.
Date
We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
Date
Parliament's Work and Pensions Committee have shared their concerns about the impact of the cost of living crisis on disabled people and urged government action to review the level of benefits.
Date
Broadcasting legend and Parkinson's UK celebrity ambassador David ‘Kid’ Jensen is taking part in a world-first clinical trial. The trial will help researchers understand if an anti-sickness drug could treat hallucinations in people with Parkinson’s or Lewy body dementia.
Date
A change to the law in England, Scotland and Wales means a wider range of healthcare professionals can now assess fitness to drive. We hope this will speed up people being able to get their driving licences.
Date
An important research partnership involving Parkinson’s UK, pharmaceutical company UCB and the Parkinson’s Foundation has published their first results in a study designed alongside people living with Parkinson’s.